Split Creek Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,225
Closed -$281K – 138
2026
Q2
$281K Buy
+2,225
New +$293K 0.26% 111

Other funds holding GILD

Split Creek Capital's GILD Position: Q3 2026 in Review

Split Creek Capital sold out of Gilead Sciences (GILD) in Q3 2026, closing a stake of 2,225 shares — an estimated $281K sold.

Split Creek Capital first reported a position in GILD in Q2 2026 and held it in 1 quarter. The position peaked at $281K in Q2 2026. 2,060 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Split Creek Capital reported no remaining Gilead Sciences position as of Q3 2026 after selling out during the quarter.
  • Split Creek Capital sold 2,225 Gilead Sciences shares in Q3 2026, an estimated $281K.
  • Split Creek Capital first reported a position in Gilead Sciences in Q2 2026 and held it in 1 quarter.
  • Split Creek Capital's Gilead Sciences position peaked at $281K in Q2 2026.
  • 2,060 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.